Tag: SARM1 inhibitors

Lilly to acquire SARM1 inhibitor developer Disarm Therapeutics

pharmanewsdaily- October 16, 2020

Lilly acquisition of Disarm Therapeutics : Eli Lilly and Company (Lilly) has agreed to acquire Disarm Therapeutics, a biotech company based in Cambridge, Massachusetts, which ... Read More